Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;129(5):e1244-51.
doi: 10.1542/peds.2011-1740. Epub 2012 Apr 16.

Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report

Ashley L Buchanan  1 , Grace Montepiedra, Patricia A Sirois, Betsy Kammerer, Patricia A Garvie, Deborah S Storm, Sharon L Nichols
Affiliations

Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report

Ashley L Buchanan et al. Pediatrics. 2012 May.

Abstract

Objective: Nonadherence to antiretroviral therapy among children/youth with HIV often is associated with disease progression. This study examined the agreement between child and caregiver perceptions of barriers to adherence and factors associated with these barriers.

Methods: Children/youth with perinatally acquired HIV and their parents/caregivers (n = 120 dyads) completed a questionnaire about 19 potential barriers to adherence to the child's antiretroviral therapy regimen. Agreement between the 2 reports was measured via the kappa statistic. Factors associated with the barriers were assessed by using multiple logistic regression.

Results: Of the 120 children, 55% were African American, 54% were boys, and the average age was 12.8 years. The most frequently reported barrier by either the caregiver or youth was "forgot." There were varying degrees of agreement between child and caregiver on the following barriers: "forgot," "taste," "child was away from home," "child refused," and "child felt good." Children who knew their HIV status were more likely to report logistical barriers, such as scheduling issues. Children with a biological parent as their caregiver were more likely to report regimen or fear of disclosure as a barrier.

Conclusions: Lack of agreement was observed for more than half of the studied barriers, indicating discrepancies between children's and caregivers' perceptions of factors that influence medication-taking. The findings suggest a need for interventions that involve both child and caregiver in the tasks of remembering when to administer the child's medications, sustaining adherence, and appropriately transitioning medication responsibility to the youth.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Child-reported barriers to adherence (n = 120).
FIGURE 2
FIGURE 2
Caregiver-reported barriers to adherence (n = 120).
See this image and copyright information in PMC

Comment in

References

    1. Patel K, Hernán MA, Williams PL, et al. Pediatric AIDS Clinical Trials Group 219/219C Study Team . Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis. 2008;46(4):507–515 - PubMed
    1. Ballif M, Ledergerber B, Battegay M, et al. Swiss HIV Cohort Study . Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007. PLoS ONE. 2009;4(12):e8275. - PMC - PubMed
    1. Carpenter CC, Cooper DA, Fischl MA, et al. . Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2000;283(3):381–390 - PubMed
    1. Brogly S, Williams P, Seage GR, III, Oleske JM, Van Dyke R, McIntosh K, PACTG 219C Team . Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice. JAMA. 2005;293(18):2213–2220 - PubMed
    1. Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR, Adolescent Medicine HIV/AIDS Research Network . Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med. 2003;157(3):249–255 - PubMed

Publication types

MeSH terms